Eric Cazergue

Eric Cazergue is the current CFO at PathoQuest. Prior to this, they served as the Finance and Operations Director Corin France from November 2018 to March 2021. Eric was also the Vice President Finance EMEA - APAC at ResMed from August 2005 to June 2018. Other notable positions include Finance Director at Sanofi Aventis Turkey from January 1996 to December 2005 and Auditor at Coopers & Lybrand from September 1991 to December 1995.

Born in 1967, Eric Cazergue graduated with a degree in business administration from the Jean Moulin Lyon 3 University in 1991. Eric began their career as a market research assistant at the French Chamber of Commerce in Turkey before moving into the finance world. Eric has since built an impressive career in finance, with a focus on strategy, business development, and operations.

Under their leadership, the Corin Group has seen strong business growth, increasing sales from 90 Mio € to 200 Mio € in just four years. Eric has also been instrumental in improving profitability after a major economic crisis. In their role as Vice President Finance EMEA - APAC at ResMed, they oversaw the finance functions for Europe, the Middle East, Africa, and Asia-Pacific. During their time at Sanofi Aventis Turkey, they contributed to the local merger process of Rhone Poulenc/HMR and subsequently between Sanofi/Aventis.

Eric Cazergue is a highly skilled and experienced finance professional with a proven track record of success. Eric is a strategic thinker with a keen eye for detail, and they are passionate about helping businesses achieve their full potential.

Eric Cazergue has a Master of Science in Business Administration from emlyon business school and a Master in Finance and Accounting from DESCF.

Eric Cazergue works with Colette Cote - Chief Portfolio Officer and General Manager, US Operations, Sébastien Renouf - Chief Pharmaceutical Officer, and Stéphane Cruveiller - Chief Technology & Information Officer. Eric Cazergue reports to Jean-François Brepson, President & CEO.